Zalewski P, Slomko J, Zawadka-Kunikowska M. Autonomic dysfunction and chronic disease.
Br Med Bull 2018;
128:61-74. [PMID:
30418540 DOI:
10.1093/bmb/ldy036]
[Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/27/2018] [Accepted: 10/11/2018] [Indexed: 12/27/2022]
Abstract
INTRODUCTION
The majority of chronic diseases are accompanied by symptoms of more or less pronounced dysautonomia, which frequently and noticeably deteriorate the quality of patients' life.
SOURCES OF DATA
Pubmed.
AREAS OF AGREEMENT
Functional disorders in the autonomic nervous system (ANS) require very precise diagnostics; frequently involving several specialists and a number of diagnostic tests.
AREAS OF CONTROVERSY
Dysautonomia symptoms are of a very discrete nature and may develop much earlier than symptoms specific for a given chronic disease, significantly influencing the treatment process itself.
GROWING POINTS
ANS dysfunctions should be considered at each stage of the diagnostic and treatment processes, as a predictor for the patient's clinical condition.
AREAS TIMELY FOR DEVELOPING RESEARCH
Many researchers indicate that a decrease in dysautonomia intensity has a direct effect on the progress of the underlying disease and undoubtedly contributes to the improvement of the general health condition or to symptoms remission.
Collapse